Yanyan Lou

University of Nottingham Ningbo China — China

Medicine · Health Sciences

41h-index8.4kcitations281works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(105), Lung Cancer Treatments and Mutations(71), Lung Cancer Research Studies(46), Immunotherapy and Immune Responses(39), CAR-T cell therapy research(38)

Publications281 total

184 Tumor biomarker analysis of anti-CD39 monoclonal antibody AB598 in a first-in-human phase I trial in patients with advanced solid tumors
Regular and Young Investigator Award Abstracts·2025Open Access
54 Development and characterization of cytokine-based classifiers to predict response to immunotherapy using an ex vivo live tumor fragment platform
Regular and Young Investigator Award Abstracts·2025Open Access
P3.18.87 EVEREST-2: Phase 1/2 Study of Logic-Gated Tmod CAR T A2B694 in Lung Cancer and Other Tumors Expressing MSLN With HLA-A*02 LOH
Journal of Thoracic Oncology·2025
Dynamic Long Short-Term Memory Based Memory Storage For Long Horizon LLM Interaction
ArXiv.org·2025Open Access
Advancements in the application of MRI radiomics in meningioma
Radiation Oncology·2025· 4 citedOpen Access
Correlation analysis of systemic immune-inflammation index values and arthritis risk in adults
Journal of International Medical Research·2025Open Access
Abstract P3-10-16: Phase I/II of Personalized Neoantigen Peptide-Based Vaccine (PNeoVCA) in Combination with Pembrolizumab in Patients with Early-Stage Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
Clinical Cancer Research·2025· 1 cited
Stroke Mortality Risk Factors: Global Trends and Regional Variations (1990–2021)
Journal of the American Heart Association·2025· 3 citedOpen Access
Assessment of survival and role of chemotherapy in patients with adrenocortical carcinoma: Insights from SEER Database (2000–2021).
Journal of Clinical Oncology·2025
A pilot single-arm, pragmatic trial in progress of in-home versus in-clinic subcutaneous nivolumab administration through Cancer Care (connected access and remote expertise) Beyond Walls (CCBW) program.
Journal of Clinical Oncology·2025· 1 cited
TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC).
Journal of Clinical Oncology·2025· 11 cited
Breaking barriers for patients with stage IV non-small cell lung cancer with brain metastases: Insight into the impact of immunotherapy on survival and survival disparities.
Journal of Clinical Oncology·2025
Immune checkpoint inhibitors (ICI) in thymic epithelial tumors (TET): A real world assessment of efficacy and toxicity.
Journal of Clinical Oncology·2025
Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution
Current Oncology Reports·2025· 4 cited
Exploring a recurrence model for atypical meningioma based on multiparametric MRI radiomic and clinical characteristics: a multicenter retrospective cohort study
Radiation Oncology·2025· 2 citedOpen Access
Supplementary Tables S1-S7 from Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations
2025Open Access
Supplementary Figures S1-S7 from Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations
2025Open Access
Data from Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations
2025· 1 citedOpen Access
Osimertinib and Cardiotoxicity: A Topic to Keep Addressing
Journal of Thoracic Oncology·2025· 1 citedOpen Access
Low-Dose Dexmedetomidine Attenuates the Dose Requirement of Propofol for Suppression of Body Movement in Patients Undergoing Operative Hysteroscopy
Drug Design Development and Therapy·2025· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Patrick Hwu(11), Rami Manochakian(11), Chengwen Liu(9), Willem W. Overwijk(9), Gregory Lizée(8), Lixia Diao(7), Weiyi Peng(6), Leng Han(6), Steven H. Lin(6), Julian A. Marin‐Acevedo(5), Bhagirathbhai Dholaria(5), Yujie Zhao(5), Youqiong Ye(5), Gordon B. Mills(5), Alex A. Adjei(5), Aixa Soyano(4), Brian Rabinovich(4), John V. Heymach(4), Chunyu Xu(4), Yan Yang(4)